RGNX – REGENXBIO Inc.
Float Short %
11.22
Margin Of Safety %
Put/Call OI Ratio
0.9
EPS Next Q Diff
1.8
EPS Last/This Y
2.46
EPS This/Next Y
-0.26
Price
9.2
Target Price
31.31
Analyst Recom
1.38
Performance Q
-9.8
Relative Volume
0.43
Beta
1.16
Ticker: RGNX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-08-15 | RGNX | 8.82 | 0.60 | 0.24 | 4056 |
| 2025-08-18 | RGNX | 8.72 | 0.60 | 1.24 | 3607 |
| 2025-08-19 | RGNX | 8.04 | 0.61 | 6.82 | 3671 |
| 2025-08-20 | RGNX | 8.06 | 0.75 | 1.22 | 4020 |
| 2025-08-21 | RGNX | 8.1 | 0.77 | 0.25 | 4072 |
| 2025-08-22 | RGNX | 9.01 | 0.77 | 2.86 | 4074 |
| 2025-08-25 | RGNX | 8.98 | 0.77 | 0.00 | 4069 |
| 2025-08-26 | RGNX | 9.13 | 0.77 | 0.06 | 4070 |
| 2025-08-27 | RGNX | 8.83 | 0.78 | 0.00 | 4056 |
| 2025-08-28 | RGNX | 9.01 | 0.77 | 2.00 | 4058 |
| 2025-08-29 | RGNX | 8.95 | 0.77 | 1.00 | 4053 |
| 2025-09-02 | RGNX | 9.11 | 0.77 | 0.00 | 4055 |
| 2025-09-03 | RGNX | 9.87 | 0.77 | 5.22 | 4067 |
| 2025-09-04 | RGNX | 9.43 | 0.95 | 0.00 | 4647 |
| 2025-09-05 | RGNX | 9.7 | 0.94 | 0.00 | 4675 |
| 2025-09-08 | RGNX | 9.49 | 0.93 | 0.50 | 4701 |
| 2025-09-09 | RGNX | 9.89 | 0.93 | 1.00 | 4707 |
| 2025-09-10 | RGNX | 9.58 | 0.93 | 0.04 | 4707 |
| 2025-09-11 | RGNX | 9.49 | 0.90 | 0.00 | 4817 |
| 2025-09-12 | RGNX | 9.21 | 0.90 | 0.00 | 4817 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-08-15 | RGNX | 8.82 | -5.0 | 113.5 | -2.03 |
| 2025-08-18 | RGNX | 8.72 | -10.2 | 112.4 | -2.03 |
| 2025-08-19 | RGNX | 8.03 | -10.2 | 117.6 | -2.03 |
| 2025-08-20 | RGNX | 8.07 | -10.2 | 111.1 | -2.03 |
| 2025-08-21 | RGNX | 8.09 | -10.2 | 111.3 | -2.03 |
| 2025-08-22 | RGNX | 9.02 | -10.2 | 102.0 | -2.13 |
| 2025-08-25 | RGNX | 8.97 | -10.2 | 111.8 | -2.13 |
| 2025-08-26 | RGNX | 9.12 | -10.2 | 110.2 | -2.13 |
| 2025-08-27 | RGNX | 8.83 | -10.2 | 113.9 | -2.13 |
| 2025-08-28 | RGNX | 9.01 | -10.2 | 110.0 | -2.13 |
| 2025-08-29 | RGNX | 8.97 | -10.2 | 111.9 | -2.13 |
| 2025-09-02 | RGNX | 9.13 | -10.2 | 109.8 | -2.13 |
| 2025-09-03 | RGNX | 9.87 | -10.2 | 270.9 | -2.13 |
| 2025-09-04 | RGNX | 9.42 | -10.2 | 242.0 | -2.13 |
| 2025-09-05 | RGNX | 9.71 | -10.2 | 258.9 | -2.13 |
| 2025-09-08 | RGNX | 9.48 | -10.2 | 247.2 | -2.13 |
| 2025-09-09 | RGNX | 9.89 | -10.2 | 261.8 | -2.13 |
| 2025-09-10 | RGNX | 9.57 | -10.2 | 245.6 | -2.13 |
| 2025-09-11 | RGNX | 9.49 | -10.2 | 250.5 | -2.13 |
| 2025-09-12 | RGNX | 9.20 | -10.2 | 245.7 | -2.13 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-08-15 | RGNX | -0.43 | -1.55 | 11.98 |
| 2025-08-18 | RGNX | -0.43 | -6.12 | 11.98 |
| 2025-08-19 | RGNX | -0.43 | -6.12 | 11.98 |
| 2025-08-20 | RGNX | -0.43 | -6.12 | 11.98 |
| 2025-08-21 | RGNX | -0.43 | -6.12 | 11.98 |
| 2025-08-22 | RGNX | -0.43 | -6.12 | 11.98 |
| 2025-08-25 | RGNX | -0.43 | -0.27 | 11.98 |
| 2025-08-26 | RGNX | -0.43 | -0.27 | 11.98 |
| 2025-08-27 | RGNX | -0.43 | -0.27 | 11.95 |
| 2025-08-28 | RGNX | -0.43 | -0.27 | 11.95 |
| 2025-08-29 | RGNX | -0.43 | -0.27 | 11.95 |
| 2025-09-02 | RGNX | -0.43 | -0.67 | 11.95 |
| 2025-09-03 | RGNX | -0.43 | -0.67 | 11.95 |
| 2025-09-04 | RGNX | -0.43 | -0.67 | 11.95 |
| 2025-09-05 | RGNX | -0.43 | -0.67 | 11.95 |
| 2025-09-08 | RGNX | -0.43 | -0.73 | 11.95 |
| 2025-09-09 | RGNX | -0.43 | -0.73 | 11.95 |
| 2025-09-10 | RGNX | -0.43 | -0.73 | 11.95 |
| 2025-09-11 | RGNX | -0.43 | -0.73 | 11.22 |
| 2025-09-12 | RGNX | -0.60 | -0.73 | 11.22 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.38
Avg. EPS Est. Current Quarter
-1.29
Avg. EPS Est. Next Quarter
0.42
Insider Transactions
-0.6
Institutional Transactions
-0.73
Beta
1.16
Average Sales Estimate Current Quarter
24
Average Sales Estimate Next Quarter
95
Fair Value
Quality Score
41
Growth Score
39
Sentiment Score
38
Actual DrawDown %
81.7
Max Drawdown 5-Year %
-89.4
Target Price
31.31
P/E
Forward P/E
PEG
P/S
2.98
P/B
2.17
P/Free Cash Flow
EPS
-3.46
Average EPS Est. Cur. Y
-2.13
EPS Next Y. (Est.)
-2.39
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-112.7
Relative Volume
0.43
Return on Equity vs Sector %
-107
Return on Equity vs Industry %
-93.9
EPS 1 7Days Diff
EPS 1 30Days Diff
-2.36
EBIT Estimation
245.7
REGENXBIO Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 353
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's products in pipeline includes ABBV-RGX-314 for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other chronic retinal diseases; and RGX-202, which is in Phase III clinical trial for the treatment of Duchenne muscular dystrophy, as well as RGX-121 for the treatment of mucopolysaccharidosis type II. It also develops RGX-111 for the treatment of mucopolysaccharidosis type I, RGX-181 for the treatment of late-infantile neuronal ceroid lipofuscinosis type 2, and RGX-381 for the treatment of the ocular manifestations of CLN2 disease. In addition, the company licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies. Further, it has a collaboration and license agreement with AbbVie Global Enterprises Ltd. to develop ABBV-RGX-314 outside the United States. REGENXBIO Inc. was incorporated in 2008 and is headquartered in Rockville, Maryland.
stock quote shares RGNX – REGENXBIO Inc. Stock Price stock today
news today RGNX – REGENXBIO Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch RGNX – REGENXBIO Inc. yahoo finance google finance
stock history RGNX – REGENXBIO Inc. invest stock market
stock prices RGNX premarket after hours
ticker RGNX fair value insiders trading